Core Insights - The article discusses various studies related to healthcare economics, focusing on cost transparency, mental health trends, and the impact of social factors on healthcare utilization and outcomes. Group 1: Healthcare Costs - The gradual disclosure of medical procedure prices on a government website led to a decrease in negotiated prices for surgical and radiology procedures by 5.1% and 9.1% respectively, primarily driven by provider-insurer negotiations rather than patient price shopping [9][11] - When primary care physicians (PCPs) are informed about specialist costs, referrals to lower-cost specialists increase by 4.6 percentage points for each rank reduction in costliness, potentially reducing referral costs by 45% in the short term [19][21] - A study on the Female Secondary School Stipend Program in Bangladesh found that it improved full immunization rates by 4.2 percentage points among children of mothers who received stipends for five years [39][40] Group 2: Mental Health - Worsening mental health has contributed to rising mortality rates among certain demographic groups, particularly non-Hispanic Whites, accounting for 9% to 29% of the increase in mortality rates [26][28][29] - Access to high-speed internet has been linked to increased mental health diagnoses and a rise in adolescent suicide rates, especially among girls [30][31] Group 3: Healthcare Demand - Non-clinical factors, such as living alone, significantly affect the length of hospital stays, particularly for elderly patients in public hospitals [36][37] - Rural populations exhibit a higher incidence of depression, with 33% to 39% of the rural-urban difference explained by factors such as income, education, and geographic region [33][34] Group 4: Neonatal Care - Advances in neonatal care have improved survival rates for high-risk newborns, but moderate-risk infants admitted to lower capability units received more intensive care, leading to reduced healthcare use post-discharge [16][18]

Core Insights - MiMedx Group, Inc. announced the publication of health economics data for the use of EPIFIX® in reconstructing cutaneous wounds after Mohs surgery, highlighting its cost-effectiveness and clinical success [1][2] Group 1: Study Findings - The study published in the Journal of Drugs in Dermatology analyzed 429 Mohs patients and demonstrated that DHACM significantly reduced adverse post-repair complications, with 97.2% of patients experiencing no complications compared to 78.7% with traditional methods [2] - Patients treated with placental allografts reached closure faster, with an average length of care of 33.3 days versus 48.3 days for those with autologous tissue repairs [2] Group 2: Industry Context - Mohs surgery is recognized as the gold standard for treating skin cancers, performed over 850,000 times annually in the U.S., primarily by dermatologists in outpatient settings [1] - The increasing evaluation of placental allografts like EPIFIX reflects a shift towards innovative approaches in high-risk surgeries, particularly as healthcare systems emphasize health economics in decision-making [2] Group 3: Company Overview - MiMedx is a leader in providing solutions for chronic and hard-to-heal wounds, with a vision to be the leading global provider of healing solutions through innovation [3]

Twenty Academic Affiliates Have Joined Compass Lexecon in the Past Six Months Affiliates Bring Prior Experience at Government Agencies Including the FTC, FCC and SEC Deep Expertise in a Wide Range of Areas, Including Merger Policy, Healthcare, AI, Finance, Venture Capital, Technology, Network Industries and Telecommunications WASHINGTON, April 02, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE:FCN) today announced that in the past six months 20 academic affiliates have joined its Compass Lexecon subsid ...